FDA faces deadline for off-label marketing guidance; J&J puts media work up for review; AMAG sets up Makena adherence plan;

> The 21st Century Cures bill includes a provision directing the FDA to get on record with its latest off-label marketing policies, with a deadline likely in mid-2017. Report

> Johnson & Johnson ($JNJ) put its global media buying and planning work up for review for the first time since 2012. Report

> AMAG Pharmaceuticals ($AMAG) partnered with NurseWise, a triage and health education provider, on MyAdherence program, designed to keep patients on schedule with injections of its preterm labor preventive Makena. Release

> The British promotional watchdog, Prescription Medicines Code of Practice Authority, cited Otsuka and ViiV in its latest round of hand-slaps. Report

> The global market for treatments for high cholesterol and other blood lipid issues will grow to $38 billion by 2023, according to GlobalData, as new meds in the PCSK9 field hit the market. Release

> Sanofi's ($SNY) consumer unit Chattem launched a battery-operated device for back pain, IcyHot Smart Relief, using packaging with vivid colors on a black background and foil stamping. Report

> The British drugmaker BTG said its recent launch of Varithena, a varicose veins treatment, is slow now, but the drug is on track to build to $500 million in peak global sales. Report

And Finally... Bayer HealthCare announced a study showing that patients suffering a pulmonary embolism (PE) aren't properly monitored afterward for the possibility of pulmonary hypertension; the company sells a PE-fighter, Xarelto, and a pulmonary hypertension treatment, Adempas. Release

Suggested Articles

Takeda’s Alunbrig has arrived in previously untreated, ALK-positive NSCLC. But there’s plenty of competition waiting to greet it at the door.

Sanofi and Regeneron's blockbuster Dupixent is eyeing an approval in eosinophilic esophagitis after cutting patients' difficulty breathing.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.